ISRCTN49277424
Completed
Not Applicable
Prevention of deep vein thrombosis: a feasibility study for a randomised trial of three different strategies to implement evidence based guidelines
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)0 sites0 target enrollmentJanuary 23, 2004
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cardiovascular diseases: Thromboembolic disease
- Sponsor
- Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Health care workers in hospital settings \- senior and junior doctors, nurses, pharmacists.
Exclusion Criteria
- •Not provided at time of registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Management of blood clots in deep veins in case of acute spinal cord injuryHealth Condition 1: null- subjects with acute spinal cord injuryCTRI/2013/08/003932Indian Spinal Injuries Centre74
Completed
Not Applicable
Critical care for prevention of deep-vein thrombosis and its psychoneurotic effects on patientspatients with esophageal cancer in the intensive-care unit.JPRN-UMIN000011722Yamaguchi University Graduate School of Medicine24
Completed
Phase 4
Prevention of Deep Vein Thrombosis (DVT) in Patients undergoing Total Knee Replacement (TKR)Surgery with Low Molecular Weight Heparin (LMWH) or outpatient Calf Compression Device (CCD) after a short course of LMWH: a randomized prospective studyDeep Venous ThrombosisBlood - Clotting disordersBlood - Haematological diseasesACTRN12613000240741Southern Sydney Hematology100
Recruiting
Not Applicable
The prevention of venous thromboembolization following by using elastic bandageVenous thromboembolizationJPRN-UMIN000043886iigata University Graduate School300
Completed
Not Applicable
Prevention of catheter-related deep vein thrombosis with nadroparin in hemato-oncology patients treated with high dose chemotherapyHemato-oncology patients with deep vein thrombosisCirculatory SystemDeep vein thrombosisISRCTN29686154Academic Medical Center (AMC) (The Netherlands)100